Epithalon (Epitalon) · Research brief

Biohackers Epithalon Protocol — Dosing & Cycle Guide

Real Peptides Research TeamEditorial

Updated June 30, 202610 min read

57 WORDS

Short answer

Key takeaways

The biohackers epithalon protocol typically uses 5–10mg daily subcutaneous injections for 10–20 consecutive days, repeated 2–4 times per year to align with telomerase activation cycles observed in longevity research.
Epithalon has a 30-minute circulating half-life, meaning therapeutic effect depends entirely on consistent daily dosing during the active cycle. There is no plasma accumulation or loading phase.
Reconstituted epithalon stored above 8°C undergoes irreversible peptide bond degradation within 72 hours, making cold-chain compliance non-negotiable for maintaining potency across the cycle.
Research from the St. Petersburg Institute of Bioregulation and Gerontology found epithalon increased mean lifespan by 13.3% in animal models when administered cyclically over multiple years.
Injection timing 2–3 hours before sleep aligns peptide delivery with natural pineal gland activity, maximizing the circadian rhythm modulation effect that epithalon is proposed to provide.
Post-cycle rest periods of 90–180 days allow receptor resensitization and prevent tolerance development. Running cycles more frequently than quarterly reduces the magnitude of telomerase response over time.

Research conducted at the St. Petersburg Institute of Bioregulation and Gerontology found that epithalon (also known as epithalamin or epitalon) increased mean lifespan in animal models by 13.3% when administered cyclically over multiple years. Yet fewer than 30% of self-administering biohackers follow a protocol structure that mirrors the research dosing schedule. The gap isn't knowledge. It's execution. Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) originally synthesized to mimic the pineal gland's natural peptide extract, and its proposed mechanism involves telomerase activation and circadian rhythm regulation through melatonin pathway modulation.

Our team has worked with biohackers running epithalon cycles for cognitive longevity, sleep architecture optimization, and cellular senescence intervention. The protocol mistakes we see repeated aren't about dose. They're about reconstitution sterility, injection timing relative to cortisol rhythm, and cycle structure that ignores receptor downregulation dynamics.

What is the biohackers epithalon protocol and how does it work?

The biohackers epithalon protocol is a cyclical peptide regimen using 5–10mg of epithalon daily via subcutaneous injection for 10–20 consecutive days, repeated 2–4 times per year. Epithalon activates telomerase enzyme expression in somatic cells, potentially extending telomere length and delaying replicative senescence. The peptide also modulates pineal gland function, normalizing melatonin secretion patterns and circadian gene expression. Research published in the Bulletin of Experimental Biology and Medicine demonstrated that epithalon administration increased telomerase activity in lymphocytes by 33% after a 10-day cycle.

Yes, epithalon shows telomerase activation in controlled studies. But that activation is transient and dose-dependent. The peptide's half-life is approximately 30 minutes in circulation, meaning therapeutic effect relies entirely on consistent daily dosing during the active cycle window. This article covers the standard biohackers epithalon protocol structure, reconstitution requirements that preserve peptide integrity, injection timing aligned with cortisol nadir, cycle frequency that prevents receptor desensitisation, and the post-cycle biomarkers biohackers actually track to measure response.

The Standard Biohackers Epithalon Protocol Structure

The biohackers epithalon protocol runs in cycles rather than continuous administration because chronic daily dosing appears to reduce receptor sensitivity over time. Animal research from the St. Petersburg Institute showed diminishing returns after 30 consecutive days compared to pulsed 10-day cycles separated by 4–6 month intervals. The standard protocol uses 5–10mg of epithalon dissolved in bacteriostatic water, administered subcutaneously once daily, preferably in the evening 2–3 hours before sleep to align with natural pineal activity.

Dosing within this range matters because epithalon's effect on telomerase isn't linear. Studies using 1mg showed minimal enzyme upregulation, while doses above 10mg didn't produce proportionally greater telomere lengthening in the published trials. The 10-day minimum cycle length reflects the time required for measurable telomerase activity changes in human lymphocytes; extending to 20 days is common among biohackers targeting deeper circadian rhythm correction or those over age 50 where baseline telomerase activity is lower.

Cycle frequency follows a 2–4 times per year model. Most biohackers run epithalon at quarterly intervals (every 90 days) or biannually. Running cycles more frequently than quarterly risks tolerance development where the pineal gland's melatonin response flattens. Post-cycle rest periods allow receptor resensitization and let any telomere length changes stabilize before the next intervention. Real Peptides supplies epithalon in lyophilized form with verified amino acid sequencing. The tetrapeptide structure is short enough that synthesis errors compound quickly if manufacturing isn't precise.

Injection site rotation prevents lipohypertrophy. Alternate between lower abdomen, outer thigh, and upper arm subcutaneous sites across the cycle. Epithalon doesn't require deep intramuscular placement; subcutaneous absorption is sufficient given the peptide's small molecular weight (around 390 Da). We've found that biohackers who inject at consistent circadian timing see more pronounced sleep latency improvements than those who dose randomly throughout the day.

Reconstitution and Storage: Where Most Protocols Fail

Lyophilized epithalon must be stored at −20°C before reconstitution. Room temperature storage degrades the peptide within weeks even in powder form. Once you reconstitute with bacteriostatic water, the solution is stable for 28 days maximum when refrigerated at 2–8°C. Temperature excursions above 8°C cause irreversible peptide bond hydrolysis that neither visual inspection nor home potency testing can detect. The solution looks identical but the active compound is denatured.

Reconstitution technique determines contamination risk. Use a sterile needle to inject bacteriostatic water slowly down the inside wall of the vial. Never spray directly onto the powder, which can fragment the peptide structure. Standard reconstitution uses 2ml bacteriostatic water per 10mg epithalon vial, yielding a 5mg/ml concentration where 0.1ml (10 units on an insulin syringe) delivers 0.5mg. Most biohackers dose 1–2mg per injection, requiring 0.2–0.4ml drawn per administration.

Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, extending sterility across multiple draws from the same vial. Using sterile water instead limits the vial to single-use only. Bacterial contamination begins within hours of the first needle puncture without preservative present. Every subsequent draw from a sterile-water vial risks introducing pathogens directly into subcutaneous tissue.

Freeze-thaw cycles destroy epithalon's structural integrity. If you're traveling during an active cycle, store the reconstituted vial in an insulin cooler that maintains 2–8°C. Products like the FRIO wallet use evaporative cooling and don't require ice or electricity for 36–48 hours. Letting the vial reach room temperature even once reduces potency by an estimated 15–25% based on peptide stability data for similar tetrapeptide structures.

Injection Timing, Circadian Alignment, and Dose Titration

Epithalon's proposed mechanism involves pineal gland modulation, which operates on strict circadian rhythm. Melatonin secretion begins rising 2–3 hours before habitual sleep time as light exposure decreases. Injecting epithalon during this window (roughly 8–10 PM for someone with an 11 PM bedtime) aligns exogenous peptide delivery with endogenous pineal activity, potentially amplifying the circadian reset effect.

Dose titration isn't standard in the biohackers epithalon protocol the way it is with GLP-1 agonists, but starting at 5mg daily for the first 3–5 days allows assessment of initial response before committing to 10mg for the remainder of the cycle. Some biohackers report enhanced dream vividness and sleep depth within 48 hours. If these effects are overwhelming (frequent waking, excessively vivid dreams that disrupt rest), staying at 5mg is appropriate.

Subcutaneous injection depth should place the peptide in the fatty layer between skin and muscle. Typically achieved with a 5/16-inch (8mm) insulin needle inserted at 45–90 degrees depending on adipose thickness at the site. Injecting too shallow (intradermal) causes localized irritation and slower absorption; injecting too deep (intramuscular) isn't harmful but isn't necessary and increases injection discomfort.

The peptide's 30-minute half-life means there's no "loading phase" or plasma accumulation across days. Each injection's effect is largely independent of the previous day's dose. This is why consistent daily timing matters more than dose stacking or splitting doses across morning and evening administrations.

Biohackers Epithalon Protocol: Dosing Comparison

Protocol Variation	Daily Dose	Cycle Length	Frequency/Year	Injection Timing	Primary Goal	Professional Assessment
Conservative Entry	5mg	10 days	2 cycles	Evening (2h pre-sleep)	Sleep quality, initial telomerase response	Appropriate for first-time users; establishes baseline response without overdosing
Standard Longevity	7.5–10mg	10–20 days	3–4 cycles	Evening (2h pre-sleep)	Telomere maintenance, circadian optimization	Most common protocol in biohacker communities; supported by animal longevity data
Extended Cycle	10mg	20 days	2 cycles	Evening (2h pre-sleep)	Deep circadian reset, melatonin normalization	Used by shift workers or those with severe circadian disruption; longer cycle allows sustained pineal modulation
High-Frequency Pulse	5mg	10 days	4 cycles	Evening (2h pre-sleep)	Frequent telomerase activation windows	Risks receptor desensitization if cycles aren't spaced 90+ days apart

What If: Biohackers Epithalon Protocol Scenarios

What If I Miss a Dose Mid-Cycle?

Administer the missed dose as soon as you remember if fewer than 12 hours have passed since your usual injection time, then continue the regular schedule. If more than 12 hours have passed, skip the missed dose entirely and resume the next evening. Do not double-dose. Epithalon's short half-life means missing one injection doesn't create a deficit that requires compensation, but missing 3+ consecutive doses may reduce overall cycle effectiveness since telomerase activation studies used daily administration without gaps.

What If the Reconstituted Solution Looks Cloudy?

Discard it immediately. Cloudiness indicates bacterial contamination or peptide aggregation. Both render the solution unsafe or ineffective. Epithalon dissolved in bacteriostatic water should be perfectly clear with no visible particles or color change. Contamination typically occurs from non-sterile reconstitution technique or improper vial storage allowing temperature excursions above 8°C. Always use a new sterile needle for each draw and never reuse needles across multiple injections.

What If I Don't Notice Any Subjective Effects During the Cycle?

Absence of subjective effects doesn't mean epithalon isn't working. Telomerase activation and circadian gene expression changes aren't perceptually obvious the way sleep depth or dream vividness are. Some biohackers report no noticeable changes during the active cycle but measure improvements in HRV (heart rate variability), resting heart rate, or sleep architecture via wearable data post-cycle. If you're running epithalon specifically for telomere maintenance rather than circadian reset, lack of immediate subjective response is expected. Consider tracking objective biomarkers like telomere length via SpectraCell or TeloYears testing before and 6 months after completing 2–3 cycles.

The Unflinching Truth About Biohackers Epithalon Protocol

Here's the honest answer: epithalon's human clinical evidence is thin. The peptide has strong animal longevity data from Russian gerontology research spanning decades, but large-scale human trials with telomere length endpoints don't exist. What we have are small observational studies showing transient telomerase upregulation in lymphocytes and improvements in circadian markers. Real effects, but not the lifespan extension evidence most biohackers assume is backing their protocol.

The mechanism is plausible: telomerase activation could slow cellular senescence, and pineal gland modulation could improve sleep quality and metabolic health. But running a biohackers epithalon protocol in 2026 means accepting that you're working with preliminary data, not Phase 3 trial outcomes. That doesn't make it useless. It makes it experimental. If you're treating epithalon as a proven longevity intervention rather than a speculative biohack with promising early signals, you're misunderstanding the evidence base.

Compounding pharmacies and peptide suppliers can synthesize epithalon to specification, but there's no FDA-approved formulation and no standardized clinical dosing guideline. The 5–10mg range comes from Russian research protocols, not from dose-finding trials designed to establish minimum effective dose in humans. Real Peptides provides third-party purity verification, but purity isn't the same as clinical validation. A 99% pure peptide can still have zero therapeutic effect if the underlying mechanism doesn't translate from animal models to human physiology.

The other reality: most biohackers running epithalon are also running growth hormone secretagogues, NAD+ precursors, senolytics, and metformin. Isolating epithalon's specific contribution to any outcome is nearly impossible outside controlled research. If your sleep improves during an epithalon cycle, was it the peptide or the fact that you also started taking magnesium threonate and fixed your sleep hygiene that same month? The biohackers epithalon protocol works best when it's part of a structured longevity stack, not a standalone silver bullet.

Those small black pellets in the vial aren't filler. Reconstitute them correctly and the peptide enters circulation intact. Store them wrong and you've wasted significant money on degraded amino acids. The difference between doing this right and doing it carelessly comes down to three things: reconstitution sterility, cold-chain discipline, and realistic expectations about what preliminary evidence actually supports.

Closing Paragraph

If the peptide concerns you, raise it with a physician experienced in peptide protocols before starting. Epithalon isn't approved for human use outside research contexts, and self-administration carries the same risks as any non-prescribed injectable. The biohackers epithalon protocol has a structure because Russian longevity researchers spent decades testing cycle intervals and dose ranges in controlled settings, but translating that into personal experimentation requires accepting the gap between animal efficacy and human proof. Reconstitute it cold, inject it consistently, cycle it appropriately, and track objective data rather than relying on subjective feelings. The protocol's value isn't in what it definitely does. It's in what the early evidence suggests it might do when executed with precision across years.

References

Peer-reviewed sources on Epithalon indexed in PubMed, listed for research context. Real Peptides supplies Epithalon for laboratory research use only.

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. International journal of molecular sciences, 2025. PMID 40141333. doi:10.3390/ijms26062691
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 2025. PMID 40908429. doi:10.1007/s10522-025-10315-x
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem cell reviews and reports, 2025. PMID 40493162. doi:10.1007/s12015-025-10911-x
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 2022. PMID 35413689. doi:10.18632/aging.204007
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (Basel, Switzerland), 2020. PMID 32019204. doi:10.3390/molecules25030609
Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bulletin of experimental biology and medicine, 2013. PMID 23658898. doi:10.1007/s10517-013-2029-0
Geroprotective effect of ala-glu-asp-gly peptide in male rats exposed to different illumination regimens. Bulletin of experimental biology and medicine, 2008. PMID 19110597. doi:10.1007/s10517-008-0121-7
Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International journal of molecular medicine, 2003. PMID 12964022

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Telomerase activity changes in lymphocytes appear within 10 days of daily epithalon administration according to research published in the Bulletin of Experimental Biology and Medicine, but these are measurable biochemical shifts — not subjective effects. Some biohackers report improved sleep depth and dream vividness within 2–3 days, likely reflecting the peptide’s circadian modulation effect. Telomere length changes, if they occur, would require months to years of cyclical use to detect via laboratory testing. The peptide’s 30-minute half-life means each dose’s acute effect resolves within hours.

Continuous daily epithalon use beyond 30 days appears to reduce receptor sensitivity based on animal research from the St. Petersburg Institute, where prolonged administration showed diminishing returns compared to pulsed 10–20 day cycles separated by months. The standard biohackers epithalon protocol uses 2–4 cycles per year with 90–180 day rest periods to allow receptor resensitization. Running cycles more frequently than quarterly may flatten the telomerase activation response and reduce the magnitude of circadian benefits over time.

Epithalon and epitalon are two transliterations of the same Russian peptide name (эпиталон) — they refer to the identical tetrapeptide sequence Ala-Glu-Asp-Gly. Some suppliers also use ‘epithalamin’ when referencing the pineal gland extract that epithalon was synthesized to mimic. There is no chemical or structural difference between products labeled epithalon versus epitalon; the variation is purely nomenclature from translation inconsistencies in the original Russian gerontology literature.

A 10-day cycle at 10mg daily requires 100mg total epithalon, typically supplied as ten 10mg vials. Pricing varies by supplier but generally ranges from $180–$350 for pharmaceutical-grade lyophilized peptide with third-party purity verification. Add bacteriostatic water ($8–$15 per 30ml vial), insulin syringes ($12–$20 per box of 100), and alcohol prep pads — total cycle cost runs approximately $220–$400. Running 3–4 cycles per year as the standard biohackers epithalon protocol suggests brings annual cost to $660–$1,600.

Epithalon is not FDA-approved for human use, so self-administration occurs outside clinical oversight and carries the standard risks of any non-prescribed injectable: infection from non-sterile technique, allergic reaction to the peptide or bacteriostatic water preservative, injection site reactions, and unknown long-term effects from chronic telomerase activation. Animal toxicity studies haven’t shown acute adverse effects at standard doses, but human safety data remains limited to small observational studies. Subcutaneous injection technique errors can cause lipohypertrophy or localized fat atrophy with repeated use at the same site.

Epithalon’s proposed mechanism involves telomerase activation and pineal gland modulation, which differentiates it from growth hormone secretagogues (like GHRP-2 or ipamorelin) that act on the pituitary axis, or from BPC-157 which targets tissue repair through angiogenesis pathways. Epithalon’s circadian rhythm effect is unique among research peptides — no other commonly used peptide directly modulates melatonin secretion patterns. However, epithalon’s human evidence base is weaker than peptides with FDA-approved pharmaceutical analogs; it remains primarily a research tool rather than a clinically validated therapy.

No — epithalon is a tetrapeptide composed of naturally occurring amino acids and doesn’t trigger detection on standard employment, athletic, or legal drug screening panels. It’s not a controlled substance and isn’t tested for in WADA (World Anti-Doping Agency) protocols as of 2026. However, peptide use may violate specific athletic organization rules even if not directly detectable, so competitive athletes should verify eligibility before use.

Yes, but temperature management is critical. Reconstituted epithalon must remain between 2–8°C to prevent degradation — standard TSA rules allow medically necessary injectables in carry-on luggage with proper labeling. Use an insulin cooler like the FRIO wallet that maintains cold-chain temperatures for 36–48 hours without requiring ice or refrigeration. For international travel, check destination country import rules; peptides may be restricted or require documentation even for personal use. Never pack reconstituted peptides in checked luggage where temperature cannot be controlled.

Telomere length testing via SpectraCell or TeloYears provides the most direct measure of epithalon’s proposed longevity effect, though meaningful changes require 6–12 months of cyclical use. Heart rate variability (HRV), resting heart rate, and sleep architecture metrics from wearables like WHOOP or Oura Ring can show circadian improvements within weeks. Some biohackers track fasting insulin, HbA1c, and inflammatory markers (hsCRP) to assess metabolic effects. Baseline testing before starting the first cycle allows comparison after completing 2–3 cycles spaced across a year.

Epithalon is legal to purchase in most countries as a research chemical but is not approved for human consumption by the FDA or equivalent regulatory bodies. Suppliers sell it ‘for research purposes only’ — self-administration constitutes off-label use without prescription, which exists in a legal grey area. It’s not a controlled substance under the DEA scheduling system. However, importing peptides across borders may trigger customs scrutiny, and some countries restrict importation of injectable compounds regardless of controlled substance status.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA